The international CAR T-cell therapy market is experiencing remarkable growth, driven by rising demand for cutting-edge cancer treatment options. This rapid expansion is fueled by elements such as the approval of CAR T-cell therapies for diverse treatments, advancements in engineering technologies, and expanding research and development efforts. F